Advarra has announced the launch of the Advarra Site-Sponsor Consortium. This collaboration, beginning with over 20 research sites, life sciences companies, standards bodies, and industry organizations, aims to connect site and sponsor technology, addressing key inefficiencies currently experienced across the clinical research ecosystem. The consortium membership will continue to expand over time to ensure this effort mirrors the diverse makeup of the clinical research ecosystem.
Read more about the new consortium here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.